About
Immuron Ltd is a publicly listed Australian bio pharmaceutical Microbiome company focused on oral immunotherapy using polyclonal antibody products for humans. Immuron is a uniquely positioned company developing therapeutic products in NASH, ASH and other diseases mediated through gut disbiosis.
Position in the VCSift Database
- • 4,609 investors in VCSift focus on the biotech sector.
- • 6 investors are based in Carlton, Victoria, Australia.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Sectors
- biotech
- Location
- Carlton, Australia
Contact Information
Find more investors like Immuron
Search Investors